BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36686705)

  • 1. Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Fang R; Hu H; Zhou Y; Wang S; Mei Z; She R; Peng X; Jiang Q; Wang X; Xie L; Lin H; Meng P; Zhang K; Wang W; Xie Y; Liu L; Tong J; Wu D; Luo Y; Liu C; Lu Y; Yu S; Cheng S; Xu L; Fang Z; Shang H; Ge J
    Front Pharmacol; 2022; 13():967457. PubMed ID: 36686705
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of Invigorating
    Wang Y; Zhang L; Pan YJ; Fu W; Huang SW; Xu B; Dou LP; Hou Q; Li C; Yu L; Zhou HF; Yang JH; Wan HT
    Front Pharmacol; 2020; 11():892. PubMed ID: 32625091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial.
    He H; Chen G; Gao J; Liu Y; Zhang C; Liu C; Li H; He Q; Li J; Wang J
    Trials; 2018 Sep; 19(1):515. PubMed ID: 30241562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.
    Zheng Y; Ching J; Cheng CW; Lam WC; Chan KL; Zhang X; Lam PY; Wu XY; Zhong LLD; Cao PH; Lo CW; Cheong PK; Lin Z; Koh M; Wu J; Bian ZX
    Chin Med; 2021 Nov; 16(1):117. PubMed ID: 34774080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of cerebral small vessel disease load scores in first-ever lacunar infarction.
    Tang R; Liu Z
    Clin Neurol Neurosurg; 2021 Jan; 200():106368. PubMed ID: 33260085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Xu X; Tian W; Duan W; Pan C; Huang M; Wang Q; Yang Q; Wen Z; Tang Y; Xiong Y; Zhu Z; Liu Y; Wei D; Qi W; Ouyang X; Ying S; Wang X; Zhou Z; Li X; Cui Y; Yang S; Xu H
    Front Pharmacol; 2022; 13():1014410. PubMed ID: 36703729
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao JN; Zhang Y; Lan X; Chen Y; Li J; Zhang P; Wu LQ; Jia ST; Liu Y; Xu FQ
    Medicine (Baltimore); 2019 Aug; 98(31):e16539. PubMed ID: 31374015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.
    Chen W; Lin J; Yang T; Xin Zhang Z; Tao L; Xiao Z; Chen H; Qi X; Sun L; Cao Y; Lin L
    Integr Cancer Ther; 2023; 22():15347354221151147. PubMed ID: 36710490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Chinese medicine Shenqi compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: Study protocol for a randomized controlled multicenter trial.
    Zhu Q; Kang J; Xu G; Li J; Zhou H; Liu Y
    Medicine (Baltimore); 2020 Mar; 99(11):e19501. PubMed ID: 32176092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional Chinese medicine syndrome differentiation and treatment by stages of Parkinson's disease: study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial.
    Hu Y; Gu S; Yuan X; Li H; Yuan C; Ye Q
    Chin Med; 2022 Jun; 17(1):68. PubMed ID: 35698234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Ruan X; Li Y; Sun Y; Jia M; Xu X; Huo L; Song W; Yao Y; Wang X
    Trials; 2021 Jul; 22(1):466. PubMed ID: 34281600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy and immunoregulatory effect of Qiangji Jianli Capsule for patients with myasthenia gravis: Study protocol for a series of randomized, controlled N-of-1 trials.
    Weng S; Fan Z; Qiu G; Liu F; Huang L; Li J; Jiang X; Song Z; Gao Y; Zhong Z; He L; Kang L; Wu Y; Chen B; Jiang Q
    Medicine (Baltimore); 2020 Dec; 99(51):e23679. PubMed ID: 33371107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial.
    Lyu J; Gao Y; Wei R; Cai Y; Shen X; Zhao D; Zhao X; Xie Y; Yu H; Chai Y; Xie Y
    Phytomedicine; 2022 Sep; 104():154278. PubMed ID: 35780589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Chinese Herbal Medicine Formula in the Treatment of Mild to Moderate Erectile Dysfunction: Study Protocol for a Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Xu RN; Ma JX; Zhang X; Liao ZD; Fu YJ; Lv BD
    Int J Gen Med; 2023; 16():5501-5513. PubMed ID: 38034900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated Virchow-Robin Spaces in First-Ever Lacunar Stroke Patients: Topography and Clinical Correlations.
    Yang H; Shen R; Jin Z; Li J; Wu Y; Xu Y; Hua T; Liu X; Huang J
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):306-11. PubMed ID: 26521169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of Qixue Tongzhi Granule in improving the exercise capacity of stable coronary artery disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Chao T; Sun J; Huan N; Ge Y; Wang C
    Front Cardiovasc Med; 2023; 10():1186018. PubMed ID: 37663413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina: A randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Sun YL; Yao YL; Jia MJ; Sun YY; Li HL; Ruan XF; Wang XL
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116959. PubMed ID: 37487965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.